Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) — Strategic Asset Allocation Index
Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a Strategic Asset Allocation Index of 29.1% as of December 2022. Strategic assets (PP&E of ₫393.80 Billion plus long-term investments of ₫-) total ₫393.80 Billion, measured against net assets of ₫1.36 Trillion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Binh Dinh Pharmaceutical and Medical Equipment JSC Strategic Asset Allocation Index (2020–2022)
This chart shows how Binh Dinh Pharmaceutical and Medical Equipment JSC's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of December 2022, the index stands at 29.1%, representing strategic assets of ₫393.80 Billion against net assets of ₫1.36 Trillion VND. Explore DBD operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Binh Dinh Pharmaceutical and Medical Equipment JSC from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see DBD company net worth.
| Year | SAAI | Strategic Assets (VND) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 29.1% | ₫393.80 Billion | ₫393.80 Billion | ₫- | ₫1.36 Trillion | ▼ -3.5 pp |
| 2021 | 32.5% | ₫371.06 Billion | ₫371.06 Billion | ₫- | ₫1.14 Trillion | ▼ -3.6 pp |
| 2020 | 36.2% | ₫357.47 Billion | ₫357.47 Billion | ₫- | ₫988.63 Billion | — |